Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Korean Journal of Obstetrics and Gynecology ; : 910-918, 2005.
Article in Korean | WPRIM | ID: wpr-107175

ABSTRACT

OBJECTIVE: to evaluate the clinicopathologic characteristics of patients with ovarian malignant germ cell tumor. METHODS: We reviewed records of women who had malignant germ cell tumors of the ovary from 1991-2000. RESULTS: Thirty-seven women had surgical resections of malignant ovarian germ cell tumors and most received adjuvant therapy. Twenty-five women (68%) presented with stage I disease, and 12 (32%) had more advanced disease. Histology subtypes were: immature teratoma (n=16), dysgerminoma (n=9), yolk sac tumor (n=8), choriocarcinoma (n=2), embryonal carcinoma (n=1), and mixed germ cell tumor (n=1). The frequency of positive tumor markers were aFP, CA-125, beta-hCG, CA 19-9 and LDH in decreasing order. The mean age of the patients at presentation was 23.9 years (4-58). Surgical management of the 32 patients consisted of unilateral oophorectomy, or salpingo-oophorectomy, 1 woman with stage III disease underwent bilateral salpingo-oophorectomy and 4 women underwent total abdominal hysterctomy, bilateral or unilateral adnexectomy. Thirty-two women were treated with adjuvant combination chemotherapy (BEP, VAC, VBP) according to indications. The 5-year survival rate was 100%, and 5-year disease-free rate was 91.8%. Among twelve patients who attempted pregnancy, 8 succeeded in it and delivered normal full term babies. CONCLUSION: Current therapeutic strategies can allow most women with ovarian malignant germ cell tumors to have conservative surgery without compromising survival and to preserve their reproductive potential.


Subject(s)
Female , Humans , Pregnancy , Carcinoma, Embryonal , Choriocarcinoma , Drug Therapy , Drug Therapy, Combination , Dysgerminoma , Endodermal Sinus Tumor , Germ Cells , Neoplasms, Germ Cell and Embryonal , Ovariectomy , Ovary , Survival Rate , Teratoma , Biomarkers, Tumor
2.
Korean Journal of Obstetrics and Gynecology ; : 1544-1549, 2005.
Article in Korean | WPRIM | ID: wpr-11428

ABSTRACT

Meigs' syndrome is characterized by the pleural effusion and ascites in patient with soild benign ovarian tumors and the resolution of the effusions after resection of the tumor. Elevated serum carbohydrate antigen 125 (CA125) levels in postmenopausal women with solid adnexal masses, ascites and pleural effusion are highly suggestive for malignant ovary tumor. As far as I know, Meigs' syndrome with hemoperitoneum due to ruptured ovarian fibroma has not been reported yet. We present a case of Meigs' syndrome associated with elevated serum CA125 and hemoperitoneum due to ruptured ovarian fibroma.


Subject(s)
Female , Humans , Ascites , Fibroma , Hemoperitoneum , Meigs Syndrome , Ovary , Pleural Effusion
3.
Korean Journal of Obstetrics and Gynecology ; : 1702-1706, 2003.
Article in Korean | WPRIM | ID: wpr-33841

ABSTRACT

OBJECTIVE: This study evaluated the possible role of 2 additional tumor markers to CA125 in discriminating between benign and malignant ovarian tumors. METHODS: Serum samples from 1,346 patients were obtained on seven days before operation. All patients underwent surgery for ovarian tumors. Serum levels of 3 tumor markers were compared to histology. Concentrations of tumor markers (CA125, CA72-4, CA19-9) were detected by enzyme immuno- or immunoradiometric assays. Normal range of these markers was defined as CA125

Subject(s)
Humans , Immunoradiometric Assay , Reference Values , Sensitivity and Specificity , Biomarkers, Tumor
SELECTION OF CITATIONS
SEARCH DETAIL